Plus Therapeutics's market cap is currently $7.08M. The company's EPS TTM is $-2.236; its P/E ratio is ―; Plus Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 4.91M	$ 224.00K	$ 0.00	$ 303.00K	$ 7.00M
Gross Profit	$ -4.78M	$ -488.00K	$ -66.00K	$ -2.40M	$ 1.63M
Operating Income	$ -13.32M	$ -19.71M	$ -12.49M	$ -9.58M	$ -3.66M
EBITDA	$ -12.69M	$ -18.85M	$ -12.49M	$ -6.76M	$ -987.00K
Net Income	$ -13.32M	$ -20.84M	$ -14.33M	$ -9.35M	$ -12.74M
Balance Sheet
Cash & Short-Term Investments	$ 8.55M	$ 18.12M	$ 18.40M	$ 8.35M	$ 17.55M
Total Assets	$ 11.39M	$ 23.87M	$ 21.98M	$ 12.11M	$ 23.23M
Total Debt	$ 4.18M	$ 5.64M	$ 6.99M	$ 7.00M	$ 11.85M
Net Debt	$ -4.37M	$ -12.47M	$ -11.41M	$ -1.35M	$ -5.70M
Total Liabilities	$ 12.74M	$ 17.42M	$ 11.14M	$ 9.07M	$ 22.07M
Stockholders' Equity	$ -1.35M	$ 6.45M	$ 10.84M	$ 3.03M	$ 1.16M
Cash Flow
Free Cash Flow	$ -13.01M	$ -13.48M	$ -10.42M	$ -8.93M	$ -5.97M
Operating Cash Flow	$ -12.85M	$ -12.97M	$ -10.28M	$ -8.43M	$ -5.91M
Investing Cash Flow	$ -160.00K	$ -759.00K	$ -82.00K	$ -493.00K	$ 5.57M
Financing Cash Flow	$ 3.44M	$ 13.45M	$ 20.42M	$ -319.00K	$ 12.63M

Currency in USD

Plus Therapeutics Earnings and Revenue History

Income Statement >

Plus Therapeutics Debt to Assets

Balance Sheet >

Plus Therapeutics Cash Flow

Cash Flow >

Plus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing